Position in CCCC
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$12,405,195
+$6,200,394 QoQ
Shares Held
2,656,359
+12.6% QoQ
Ownership
2.16%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#15
of 147 holders
Holding Since
Dec 2020
23 quarters on record
Voting authority
Sole 90%
Shared 0%
None 10%
Common Shares in CCCC Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026BANK OF AMERICA CORP /DE/ holds $10,050,306,032 across 338 Biotechnology names. CCCC ranks #105 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,039,178 | $1,509,650,884 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,291,053 | $805,023,185 | |
| 3 | CYTK |
Cytokinetics Inc
|
4,635,709 | $394,916,048 | |
| 4 | ARGX |
Argenx SE
|
400,234 | $371,325,094 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
994,476 | $299,367,107 | |
| 6 | JAZZ |
Jazz Pharmaceuticals plc
|
1,136,091 | $273,763,844 | |
| 7 | TVTX |
Travere Therapeutics, Inc.
|
4,568,341 | $259,527,450 | |
| 8 | RPRX |
Royalty Pharma plc
|
4,149,422 | $232,658,090 |
All Filings in CCCC
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $12,405,195 | 2,656,359 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $6,204,801 | 2,359,241 | Shares | Defined | 2026-05-18 | |
| 2025-12-31 | $4,560,288 | 2,387,586 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $4,558,019 | 2,053,162 | Shares | Defined | 2026-02-03 | |
| 2025-06-30 | $2,871,444 | 2,008,004 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $3,185,318 | 1,990,824 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $6,039,510 | 1,677,642 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $11,606,527 | 2,036,233 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $8,170,464 | 1,768,499 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $15,156,640 | 1,855,158 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $9,464,297 | 1,675,097 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $84,332 | 45,341 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $92,588 | 33,669 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $161,671 | 51,488 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $1,151,420 | 195,156 | Shares | Defined | 2023-02-10 | |
| 2022-09-30 | $1,220,669 | 139,187 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $463,792 | 61,511 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $2,517,654 | 103,778 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $3,273,870 | 101,673 | Shares | Defined | 2022-02-08 | |
| 2021-09-30 | $962,898 | 21,551 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $1,298,101 | 34,305 | Shares | Defined | 2021-09-13 | |
| 2021-03-31 | $1,804,149 | 48,774 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $203,086 | 6,130 | Shares | Defined | 2021-02-10 | |
| No filing history on record for this holder in this stock. | ||||||